$12.34
Price
$1.3B
Market Cap
—
P/E Ratio
-22.7
Forward P/E
$-1.52
EPS (TTM)
—
Dividend Yield
$452M
Cash
$3M
Total Debt
103M
Shares Out
$5.63
$13.53
52-Week Range
Institutional Ownership of DAY ONE BIOPHARMACEUTICALS I
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for DAY ONE BIOPHARMACEUTICALS I
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2024-Q4 | |||||
| SELL | EXIT | — | — | $13.80 | |
| 2023-Q2 | |||||
| BUY | +64.2% | 2.6M | $31M | $13.08 | |
| 2022-Q3 | |||||
| SELL | -16.1% | 1.6M | $31M | $20.45 | |
| 2022-Q2 | |||||
| BUY | +53.3% | 1.9M | $33M | $9.50 | |
| 2022-Q1 | |||||
| BUY | +4.7% | 1.2M | $29M | $13.74 | |
| 2021-Q4 | |||||
| SELL | -4.5% | 1.2M | $20M | $20.86 | |
| 2021-Q3 | |||||
| SELL | -9.7% | 1.2M | $29M | $23.90 | |
| 2021-Q2 | |||||
| BUY | NEW | 1.3M | $31M | $20.44 | |
Insider Trading for DAY ONE BIOPHARMACEUTICALS I
6 Months Insider Sentiment
Buy $0
Sell $250K
0
Buys
4
Sells
-250K
Net
2
Grants
Largest
$142K
Bender
$39K
Dubow
$36K
II
| Date |
Insider
Click to search
|
Role
Click to search
|
Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Nov 25, 2025 | Jeremy Bender | CHIEF EXECUTIVE OFFICER | GRANT | 7.2K | — | — |
| Nov 25, 2025 | Jeremy Bender | CHIEF EXECUTIVE OFFICER | GRANT | 300.0K | — | — |
| Nov 17, 2025 | Jeremy Bender | CHIEF EXECUTIVE OFFICER | SELL | 15.9K | $8.91 | $142K |
| Nov 17, 2025 | Charles N York II | COO and CFO | SELL | 4.1K | $8.91 | $36K |
| Nov 17, 2025 | Adam Dubow | Gen Counsel & Secretary | SELL | 4.3K | $8.91 | $39K |
| Nov 17, 2025 | Lauren Merendino | Chief Commercial Officer | SELL | 3.7K | $8.91 | $33K |